» Articles » PMID: 27405960

Biochemical and Biophysical Cues in Matrix Design for Chronic and Diabetic Wound Treatment

Overview
Date 2016 Jul 14
PMID 27405960
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Progress in biomaterial science and engineering and increasing knowledge in cell biology have enabled us to develop functional biomaterials providing appropriate biochemical and biophysical cues for tissue regeneration applications. Tissue regeneration is particularly important to treat chronic wounds of people with diabetes. Understanding and controlling the cellular microenvironment of the wound tissue are important to improve the wound healing process. In this study, we review different biochemical (e.g., growth factors, peptides, DNA, and RNA) and biophysical (e.g., topographical guidance, pressure, electrical stimulation, and pulsed electromagnetic field) cues providing a functional and instructive acellular matrix to heal diabetic chronic wounds. The biochemical and biophysical signals generally regulate cell-matrix interactions and cell behavior and function inducing the tissue regeneration for chronic wounds. Some technologies and devices have already been developed and used in the clinic employing biochemical and biophysical cues for wound healing applications. These technologies can be integrated with smart biomaterials to deliver therapeutic agents to the wound tissue in a precise and controllable manner. This review provides useful guidance in understanding molecular mechanisms and signals in the healing of diabetic chronic wounds and in designing instructive biomaterials to treat them.

Citing Articles

Understanding molecular mechanism of diabetic wound healing: addressing recent advancements in therapeutic managements.

Porel P, Kaur M, Sharma V, Aran K J Diabetes Metab Disord. 2025; 24(1):76.

PMID: 40060271 PMC: 11883079. DOI: 10.1007/s40200-025-01588-7.


Fabrication and Characterization of Oxygen-Generating Polylactic Acid/Calcium Peroxide Composite Filaments for Bone Scaffolds.

Mohammed A, Saeed A, ElShaer A, Melaibari A, Memic A, Hassanin H Pharmaceuticals (Basel). 2023; 16(4).

PMID: 37111384 PMC: 10143609. DOI: 10.3390/ph16040627.


Biophysical and Biochemical Cues of Biomaterials Guide Mesenchymal Stem Cell Behaviors.

Li J, Liu Y, Zhang Y, Yao B, Enhejirigala , Li Z Front Cell Dev Biol. 2021; 9:640388.

PMID: 33842464 PMC: 8027358. DOI: 10.3389/fcell.2021.640388.


Needle-injectable microcomposite cryogel scaffolds with antimicrobial properties.

Joshi Navare K, Colombani T, Rezaeeyazdi M, Bassous N, Rana D, Webster T Sci Rep. 2020; 10(1):18370.

PMID: 33110210 PMC: 7591905. DOI: 10.1038/s41598-020-75196-1.


Oxygen-Releasing Antibacterial Nanofibrous Scaffolds for Tissue Engineering Applications.

Abdullah T, Gauthaman K, Hammad A, Joshi Navare K, Alshahrie A, Bencherif S Polymers (Basel). 2020; 12(6).

PMID: 32485817 PMC: 7361702. DOI: 10.3390/polym12061233.


References
1.
Xu J, Rodriguez D, Petitclerc E, Kim J, Hangai M, Moon Y . Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol. 2001; 154(5):1069-79. PMC: 2196184. DOI: 10.1083/jcb.200103111. View

2.
Gallagher K, Liu Z, Xiao M, Chen H, Goldstein L, Buerk D . Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest. 2007; 117(5):1249-59. PMC: 1857264. DOI: 10.1172/JCI29710. View

3.
Yang X, Wang J, Guo S, Fan K, Li J, Wang Y . miR-21 promotes keratinocyte migration and re-epithelialization during wound healing. Int J Biol Sci. 2011; 7(5):685-90. PMC: 3107477. DOI: 10.7150/ijbs.7.685. View

4.
Wang Y, Liou N, Cherng J, Chang S, Ma K, Fu E . siRNA-targeting transforming growth factor-β type I receptor reduces wound scarring and extracellular matrix deposition of scar tissue. J Invest Dermatol. 2014; 134(7):2016-2025. DOI: 10.1038/jid.2014.84. View

5.
Trentin D, Hall H, Wechsler S, Hubbell J . Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A. 2006; 103(8):2506-11. PMC: 1413769. DOI: 10.1073/pnas.0505964102. View